Zidovudine, lamivudine and dolutegravir (AXD) Relative to Tenofovir, lamivudine and dolutegravir (TXD) In Second Line Antiretroviral Therapy (ARTIST) Trial: a randomised controlled trial
-
Location
-
Topic
-
Methodology
-
ReferenceOCB020-1901
Purpose of study
Purpose of study
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Protocol added by Petros Isaakidis
10th February 2020ARTIST_Protocol_V2.1_27_March_2019_clean.doc445 KB -
ERB documentation added by Petros Isaakidis
10th February 2020MSF_ERB_approval_protocol_1901_28Mar19.pdf121 KB -
ERB documentation added by Petros Isaakidis
10th February 2020SKM_28719041008580.pdf49.7 KB
Documents
-
SKM_28719041008580.pdf 49.7 KB
Publications
No publications recorded
Previous study
Next study